Assessment of fracture risk

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD). There are a number of clinical risk factors that provide information on fracture risk over and above that given by BMD. The assessment of fracture risk thus needs to be distinguished from diagnosis to take account of the independent value of the clinical risk factors. These include age, a prior fragility fracture, a parental history of hip fracture, smoking, use of systemic corticosteroids, excess alcohol intake and rheumatoid arthritis. The independent contribution of these risk factors can be integrated by the calculation of fracture probability with or without the use of BMD. Treatment can then be offered to those identified to have a fracture probability greater than an intervention threshold.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Anonymous (1993) Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650

    Article  PubMed  Google Scholar 

  2. 2.

    Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406

    CAS  PubMed  Google Scholar 

  3. 3.

    Royal College of Physicians (1999) Clinical guidelines for the prevention and treatment of osteoporosis. RCP, London

  4. 4.

    National Osteoporosis Foundation (1998) Analyses of the effectiveness and cost of screening and treatment strategies for osteoporosis: a basis for development of practice guidelines. Osteoporos Int 8 (suppl 4):1–88

    Article  Google Scholar 

  5. 5.

    Kanis JA, Glüer CC for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202

    Article  CAS  PubMed  Google Scholar 

  6. 6.

    Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C et al. (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13:527–536

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. WHO, Geneva

  8. 8.

    Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:17–1141

    CAS  PubMed  Google Scholar 

  9. 9.

    Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteoporosis and osteopenia. Bone 27:585–590

    Article  CAS  PubMed  Google Scholar 

  10. 10.

    Committee for Proprietary Medicinal Products (CPMP) (1997) Note for guidance on involutional osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95)

  11. 11.

    World Health Organisation (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneva

  12. 12.

    Liu, Z, Piao J, Pang L, Qing X et al. (2002) The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China. J Bone Miner Metab 20:181–189

    Article  PubMed  Google Scholar 

  13. 13.

    Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int 69:218–221

    CAS  PubMed  Google Scholar 

  14. 14.

    DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593

    PubMed  Google Scholar 

  15. 15.

    Ross P, Huang C, Davis J, Imose K, Yates J, Vogel J, Wasnich R (1995) Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneous ultrasound. Bone 16:325–332

    Article  CAS  PubMed  Google Scholar 

  16. 16.

    Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J (1997) Bone density variation and its effect on risk of vertebral deformity in men and women studied in thirteen European Centres: the EVOS Study. J Bone Miner Res 12:1883–1894

    CAS  PubMed  Google Scholar 

  17. 17.

    Faulkner KG, von Stetten E, Miller P (1999) Discordance in patient classification using T-scores. J Clin Densitom 2:343–350

    Article  CAS  PubMed  Google Scholar 

  18. 18.

    Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD (1997) Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 12:683–690

    Google Scholar 

  19. 19.

    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259

    CAS  PubMed  Google Scholar 

  20. 20.

    Cooper C, Aihie A (1994) Osteoporosis: recent advances in pathogenesis and treatment. Q J Med 87:203–209

    CAS  PubMed  Google Scholar 

  21. 21.

    Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2001) Ten year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258

    Article  Google Scholar 

  22. 22.

    Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W (2000) Risk of hip fracture in Sweden according to relative risk: an analysis applied to the population of Sweden. Osteoporos Int 11:120–127

    CAS  PubMed  Google Scholar 

  23. 23.

    Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 26:387–391

    Article  CAS  PubMed  Google Scholar 

  24. 24.

    Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1999) Lifetime risk of hip fracture is underestimated. Osteoporos Int 8:599–603

    Article  Google Scholar 

  25. 25.

    Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809

    CAS  PubMed  Google Scholar 

  26. 26.

    Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995

    Article  CAS  PubMed  Google Scholar 

  27. 27.

    Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936

    Article  PubMed  Google Scholar 

  28. 28.

    Johnell O, Gullberg B, Kanis JA et al. (1995) Risk factors for hip fracture in European women: the MEDOS Study. J Bone Miner Res 10:1802–1815

    CAS  PubMed  Google Scholar 

  29. 29.

    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767–773

    Article  CAS  PubMed  Google Scholar 

  30. 30.

    Compston JE (1992) Risk factors for osteoporosis. Clin Endocrinol 36:223–224

    CAS  Google Scholar 

  31. 31.

    Ribot C, Pouilles JM, Bonneu M, Tremollieres F (1992) Assessment of the risk of postmenopausal osteoporosis using clinical risk factors. Clin Endocrinol 36:225–228

    CAS  Google Scholar 

  32. 32.

    Kanis JA, Johnell O, Gullberg B, Allander A, Elffors L, Dequeker J et al. (1999) Risk factors for hip fracture in European men. The MEDOS study. Osteoporos Int 9:45–54

    Article  CAS  PubMed  Google Scholar 

  33. 33.

    Nguyen T, Sambrook SP, Kelly P, Jones G, Freund J, Eisman J (1993) Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307:1111–1115

    CAS  PubMed  Google Scholar 

  34. 34.

    Poor G, Atkinson EJ, O’Fallon WM, Melton LJ III (1995) Predictors of hip fractures in elderly men. J Bone Miner Res 10:1900–1907

    CAS  PubMed  Google Scholar 

  35. 35.

    Kanis JA, McCloskey EV (1996) Evaluation of the risk of hip fracture. Bone 18:127–132

    Article  Google Scholar 

  36. 36.

    Kanis JA, De Laet C, Delmas P, Garnero P, Johansson H, Johnell O, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Oden A, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and fracture risk. Bone 35:375–382

    Article  Google Scholar 

  37. 37.

    Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899

    PubMed  Google Scholar 

  38. 38.

    Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman AJ, Tenenhouse A (2004) Smoking and fracture risk: a meta-analysis. Osteoporos Int (in press)

    Google Scholar 

  39. 39.

    Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ, Pols HAP, Reeve J, Silman AJ, Tenenhouse A (2004) A family history of fracture and fracture risk: a meta-analysis. Bone (in press)

    Google Scholar 

  40. 40.

    De Laet C, Kanis JA, Oden A, Johansson H, Johnell O, Delmas P et al. (2004) Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int (in press)

    Google Scholar 

  41. 41.

    Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2004) Alcohol intake as a risk factor for fracture. Osteoporos Int (in press)

  42. 42.

    Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2001) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    Google Scholar 

  43. 43.

    Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787

    PubMed  Google Scholar 

  44. 44.

    Klotzbuecher CM, Ross PD, Landsman PB, Abbot TA, Berger M (2000) Patients with prior fractures have increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–727

    CAS  PubMed  Google Scholar 

  45. 45.

    Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non black, osteoporotic women. Osteoporos Int 3:120–126

    CAS  PubMed  Google Scholar 

  46. 46.

    Delmas PD (ed) (2000) The use of biochemical markers of bone turnover in the management of post-menopausal osteoporosis. Osteoporosis Int 11:S1–S76

    Article  Google Scholar 

  47. 47.

    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women. The Ofely study. J Bone Miner Res 15:1526–1536

    CAS  PubMed  Google Scholar 

  48. 48.

    Garnero P, Hauser E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breard G, Meunier PJ, Delmas PD (1996) Markers of bone turnover predict hip fractures in elderly women. The EPIDOS prospective study. J Bone Miner Res 11:1531–1538

    CAS  PubMed  Google Scholar 

  49. 49.

    Hansen M, Overgaard K, Riis B, Christiansen C (1991) Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303:961–964

    CAS  PubMed  Google Scholar 

  50. 50.

    Johnell O, Oden A, DeLaet C, Garnero P, Delmas PD, Kanis JA (2002) Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523–526

    Article  CAS  PubMed  Google Scholar 

  51. 51.

    Dyslipidaemia Advisory Group on behalf of the Scientific Committee of the National Heart Foundation of New Zealand (1996) National Heart Foundation Clinical Guidelines for the assessment and management of dyslipidaemia. N Z Med J 109:224–232

    PubMed  Google Scholar 

  52. 52.

    Kanis JA, Dawson A, Oden A, Johnell O, De Laet C, Jonsson B (2001) Cost-effectiveness of preventing hip fracture in the general female population. Osteoporos Int 12:356–361

    Article  CAS  PubMed  Google Scholar 

  53. 53.

    Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20–26

    Article  CAS  PubMed  Google Scholar 

  54. 54.

    Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427

    Article  CAS  PubMed  Google Scholar 

  55. 55.

    Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jonsson B (2002) Intervention thresholds for osteoporosis. Bone 13:26–31

    Google Scholar 

  56. 56.

    Kanis JA, Barton IP, Johnell O (2004) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (in press)

  57. 57.

    Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA (2004) Optimisation of BMD measurements to identify high risk groups for treatment—a test analysis. J Bone Miner Res 19:906–913

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to John A. Kanis.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kanis, J.A., Borgstrom, F., De Laet, C. et al. Assessment of fracture risk. Osteoporos Int 16, 581–589 (2005). https://doi.org/10.1007/s00198-004-1780-5

Download citation

Keywords

  • Case-finding
  • Clinical risk factors
  • Fracture probability
  • Intervention threshold